Aug 25 2020 |
OCR Updates Guidance to Clarify That Health Plans May Contact Recovered COVID-19 Patients About Plasma Donation |
Mintz |
Aug 24 2020 |
HSS Rescinds FDA's "Informal" Ability to Require Premarket Review pf LDTS Without Formal Rulemaking |
McDermott Will & Schulte LLP |
Aug 24 2020 |
Telehealth: New Executive Order and CY2021 Proposed Regulatory Changes |
Polsinelli PC |
Aug 24 2020 |
CMS Announces New Payment Model for Rural Providers |
Steptoe & Johnson PLLC |
Aug 24 2020 |
ERISA Plan Participants Cannot Proceed As A Class In Challenging EpiPen Prices |
Proskauer Rose LLP |
Aug 24 2020 |
Most-Favored Nation Update |
Giordano, Halleran & Ciesla, P.C. |
Aug 24 2020 |
Public Hospital M&A: Know Your Stakeholders |
McDermott Will & Schulte LLP |
Aug 22 2020 |
COVID-19: US State Policy Report – August 21, 2020 |
Squire Patton Boggs (US) LLP |
Aug 21 2020 |
July and August 2020 State Regulatory Developments |
Giordano, Halleran & Ciesla, P.C. |
Aug 21 2020 |
“Because of Bostock ” – Court Delays HHS Rule Re-interpreting Section 1557 Discrimination “Because of Sex” |
McDermott Will & Schulte LLP |
Aug 21 2020 |
COVID-19: US State Policy Report – August 20, 2020 |
Squire Patton Boggs (US) LLP |
Aug 21 2020 |
Court Decision Restores Affordable Care Act’s Discrimination Protections for Transgender Patients |
Jackson Lewis P.C. |
Aug 20 2020 |
Healthcare's New Normal: CMS Directs States to Resume Routine Surveys and Enforcement |
McDermott Will & Schulte LLP |
Aug 20 2020 |
Potential Embarrassment Insufficient to Enable Plaintiffs to Litigate Anonymously in Breast Implant MDL |
Faegre Drinker |
Aug 20 2020 |
K&L Gates Triage: HIPAA: Do Hospitals Need a Business Associate Agreement with their Health System Parent Corporation? [PODCAST] |
K&L Gates LLP |
Aug 20 2020 |
Digital Health at Scale: The Payor Perspective |
McDermott Will & Schulte LLP |
Aug 19 2020 |
Driving the Deal: Public Hospital M&A and Stakeholder Buy-In [Podcast] |
McDermott Will & Schulte LLP |
Aug 19 2020 |
Bioethics in a Pandemic: Vaccine Distribution |
Mintz |
Aug 19 2020 |
President Trump’s Executive Order Mandating the Purchase of U.S. Drugs Evokes Criticism |
Sheppard, Mullin, Richter & Hampton LLP |
Aug 18 2020 |
CMS’ Proposed Rule Promoting Value-Based Purchasing for Medicaid-Covered Drugs: The Comments are In! |
Sheppard, Mullin, Richter & Hampton LLP |
Aug 18 2020 |
FDA Announcement Regarding Cyclospora Illness Investigation Showcases New Technology and Previews Coming Changes |
Keller and Heckman LLP |
Aug 18 2020 |
Luxembourg Employers Face Additional Obligations During Heat Waves in the Midst of COVID-19 |
Epstein Becker & Green, P.C. |
Aug 17 2020 |
Top 7 Things Health and Welfare Sponsors Should Be Thinking About Now |
Faegre Drinker |
Aug 17 2020 |
Kamala Harris – Where the Vice Presidential Nominee Stands on Key Healthcare Issues |
Squire Patton Boggs (US) LLP |
Aug 17 2020 |
Remote Care Providers Await Final New Jersey Registration and Reporting Regulations |
McDermott Will & Schulte LLP |
Aug 17 2020 |
IRS Issues REIT-Favorable Ruling for Taxable REIT Subsidiary in Private Equity International Healthcare Acquisition |
McDermott Will & Schulte LLP |
Aug 17 2020 |
COVID-19 : Return to Work And Partial Activity (II) |
K&L Gates LLP |
Aug 16 2020 |
COVID-19: US State Policy Report – August 14, 2020 |
Squire Patton Boggs (US) LLP |
Aug 14 2020 |
COVID-19 Weekly Newsletter: Questions Swirl Around Federal Response, Back-to-School Plans as COVID-19 Studies Continue |
Faegre Drinker |
Aug 14 2020 |
McDermottPlus Check-Up: August 14, 2020 |
McDermott Will & Schulte LLP |
Aug 14 2020 |
August 2020 Updated: CMS Final Rule Aims to Advance Interoperability, Exchange of Clinical and Plan Information |
McDermott Will & Schulte LLP |
Aug 14 2020 |
Public Records Show Agencies Are Vigorously Enforcing New COVID-19 Requirements Against Healthcare Providers |
Squire Patton Boggs (US) LLP |
Aug 13 2020 |
Treats Act Aims to Expand Use of Telehealth to Treat Substance Use Disorder |
McDermott Will & Schulte LLP |
Aug 13 2020 |
CMS Takes a Preliminary Step to Make Certain COVID-19 Waivers Permanent |
McDermott Will & Schulte LLP |
Aug 13 2020 |
COVID-19: US State Policy Report – August 12, 2020 |
Squire Patton Boggs (US) LLP |